In a filing with Bursa Malaysia, the pharmaceutical group attributed the topline and bottomline’s stellar performance to the supply of Sinovac Covid-19 vaccine to the Ministry of Health (MoH) and the private sector.
PETALING JAYA: Pharmaniaga Bhd
is back in the black, posting a net profit of RM85.5mil in the fourth quarter ended Dec 31, 2021, compared to losses of RM6.33mil a year earlier.
Its revenue for the quarter surged 12.2% to RM711.72mil from RM634.58mil previously.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
